Literature DB >> 19578477

Concepts in the pathogenesis of rabies.

Bernhard Dietzschold1, Jianwei Li, Milosz Faber, Matthias Schnell.   

Abstract

Rabies is a zoonotic disease that remains an important public health problem worldwide and causes more than 70,000 human deaths each year. The causative agent of rabies is rabies virus (RV), a negative-stranded RNA virus of the rhabdovirus family. Neuroinvasiveness and neurotropism are the main features that define the pathogenesis of rabies. Although RV pathogenicity is a multigenic trait involving several elements of the RV genome, the RV glycoprotein plays a major role in RV pathogenesis by controlling the rate of virus uptake and trans-synaptic virus spread, and by regulating the rate of virus replication. Pathogenic street RV strains differ significantly from tissue culture-adapted RV strains in their neuroinvasiveness. Whereas street RV strains are highly neuroinvasive, most tissue culture-adapted RV strains have either no or only limited ability to invade the CNS from a peripheral site. The high neuroinvasiveness of pathogenic street RVs is, at least in part, due to their ability to evade immune responses and to conserve the structures of neurons. The finding that tissue culture-adapted RV strains replicate very fast and induce strong innate and adaptive immune responses opens new avenues for therapeutic intervention against rabies.

Entities:  

Year:  2008        PMID: 19578477      PMCID: PMC2600441          DOI: 10.2217/17460794.3.5.481

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  70 in total

1.  A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity.

Authors:  Milosz Faber; Marie-Luise Faber; Amy Papaneri; Michael Bette; Eberhard Weihe; Bernhard Dietzschold; Matthias J Schnell
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery.

Authors:  N D Mazarakis; M Azzouz; J B Rohll; F M Ellard; F J Wilkes; A L Olsen; E E Carter; R D Barber; D F Baban; S M Kingsman; A J Kingsman; K O'Malley; K A Mitrophanous
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

3.  Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic type G proteins of the rabies virus.

Authors:  K Morimoto; Y J Ni; A Kawai
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

Review 4.  Subversive neuroinvasive strategy of rabies virus.

Authors:  M Lafon
Journal:  Arch Virol Suppl       Date:  2004

5.  Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.

Authors:  K Morimoto; D C Hooper; S Spitsin; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 6.  NLRs at the intersection of cell death and immunity.

Authors:  Jenny P-Y Ting; Stephen B Willingham; Daniel T Bergstralh
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

7.  Evidence for an intraaxonal transport of fixed and street rabies virus.

Authors:  H Tsiang
Journal:  J Neuropathol Exp Neurol       Date:  1979-05       Impact factor: 3.685

8.  Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.

Authors:  B Dietzschold; W H Wunner; T J Wiktor; A D Lopes; M Lafon; C L Smith; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Alteration of potassium-evoked 5-HT release from virus-infected rat cortical synaptosomes.

Authors:  E Bouzamondo; A Ladogana; H Tsiang
Journal:  Neuroreport       Date:  1993-05       Impact factor: 1.837

10.  Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.

Authors:  D C Hooper; K Morimoto; M Bette; E Weihe; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  52 in total

1.  Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons.

Authors:  Ian R Wickersham; Heather A Sullivan; H Sebastian Seung
Journal:  Nat Protoc       Date:  2010-03-04       Impact factor: 13.491

Review 2.  Trans-synaptic Neural Circuit-Tracing with Neurotropic Viruses.

Authors:  Jiamin Li; Taian Liu; Yun Dong; Kunio Kondoh; Zhonghua Lu
Journal:  Neurosci Bull       Date:  2019-04-19       Impact factor: 5.203

3.  [Rabies transmission through organ transplantation].

Authors:  P Wohlsein; W Baumgärtner; H H Kreipe; A Haverich; A Hori; A C Stan
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

4.  Case Report: Failure of Therapeutic Coma in Rabies Encephalitis.

Authors:  Abi Manesh; Reeta Subramaniam Mani; Kishore Pichamuthu; Manjeera Jagannati; Vivek Mathew; Rajiv Karthik; Ooriapadickal Cherian Abraham; Geeta Chacko; George M Varghese
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

5.  Establishment of a longitudinal pre-clinical model of lyssavirus infection.

Authors:  Kate E Mastraccio; Celeste Huaman; David Warrilow; Greg A Smith; Scott B Craig; Dawn L Weir; Eric D Laing; Ina L Smith; Christopher C Broder; Brian C Schaefer
Journal:  J Virol Methods       Date:  2020-05-12       Impact factor: 2.014

6.  Stability of vaccinia-vectored recombinant oral rabies vaccine under field conditions: a 3-year study.

Authors:  Joseph R Hermann; Alethea M Fry; David Siev; Dennis Slate; Charles Lewis; Donna M Gatewood
Journal:  Can J Vet Res       Date:  2011-10       Impact factor: 1.310

7.  Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues.

Authors:  Jianwei Li; Adam Ertel; Carla Portocarrero; Darryll A Barkhouse; Bernhard Dietzschold; D Craig Hooper; Milosz Faber
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

8.  Characterization of a single-cycle rabies virus-based vaccine vector.

Authors:  Emily A Gomme; Elizabeth J Faul; Phyllis Flomenberg; James P McGettigan; Matthias J Schnell
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

9.  Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies.

Authors:  Yange Niu; Ye Liu; Limin Yang; Hongren Qu; Jingyi Zhao; Rongliang Hu; Jing Li; Wenjun Liu
Journal:  Virol Sin       Date:  2016-04-06       Impact factor: 4.327

10.  Rabies Virus CVS-N2c(ΔG) Strain Enhances Retrograde Synaptic Transfer and Neuronal Viability.

Authors:  Thomas R Reardon; Andrew J Murray; Gergely F Turi; Christoph Wirblich; Katherine R Croce; Matthias J Schnell; Thomas M Jessell; Attila Losonczy
Journal:  Neuron       Date:  2016-01-21       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.